Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Innodata
INOD
$2.05B
| $647K | ﹤0.01% |
38,557
+29,470
| +324% | +$496K |
|
3527
Bally's
BALY
$682M
| $645K | ﹤0.01% |
37,419
+14,567
| +64% | +$233K |
|
3528
MaxCyte
MXCT
$112M
| $645K | ﹤0.01% |
165,765
+127,156
| +329% | +$536K |
|
3529
Direxion Daily Technology Bull 3x ETF
TECL
$5.08B
| $643K | ﹤0.01% |
7,345
+1,645
| +29% | +$139K |
|
3530
Codexis
CDXS
$151M
| $639K | ﹤0.01% |
207,628
+70,255
| +51% | +$217K |
|
3531
Anterix
ATEX
$1.81B
| $639K | ﹤0.01% |
16,971
+12,484
| +278% | +$481K |
|
3532
Preformed Line Products
PLPC
$1.75B
| $639K | ﹤0.01% |
4,989
+2,871
| +136% | +$348K |
|
3533
CALL
Abbott
ABT
$183B
| $638K | ﹤0.01% |
5,600
-404,000
| -99% | -$44.3M |
|
3534
Aveanna Healthcare
AVAH
$2.04B
| $638K | ﹤0.01% |
122,689
+54,557
| +80% | +$247K |
|
3535
Grupo Cibest SA
CIB
$22B
| $637K | ﹤0.01% |
20,286
| – | – |
|
3536
Calumet Specialty Products
CLMT
$3.85B
| $635K | ﹤0.01% |
+35,645
| New | +$571K |
|
3537
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $635K | ﹤0.01% |
+4,800
| New | +$607K |
|
3538
Schneider National
SNDR
$6.26B
| $631K | ﹤0.01% |
22,118
-32,023
| -59% | -$847K |
|
3539
CALL
AMC Entertainment Holdings
AMC
$2.52B
| $631K | ﹤0.01% |
138,700
+19,600
| +16% | +$97.7K |
|
|
EVBN
3540
DELISTED
Evans Bancorp Inc
EVBN
| $630K | ﹤0.01% |
16,163
+5,218
| +48% | +$179K |
|
3541
Nu Skin
NUS
$252M
| $630K | ﹤0.01% |
85,437
+67,016
| +364% | +$626K |
|
3542
CorMedix
CRMD
$591M
| $629K | ﹤0.01% |
77,870
-84,122
| -52% | -$455K |
|
3543
Build-A-Bear
BBW
$425M
| $627K | ﹤0.01% |
18,246
+13,810
| +311% | +$389K |
|
|
EHAB
3544
DELISTED
Enhabit
EHAB
| $627K | ﹤0.01% |
79,321
-234,757
| -75% | -$2.04M |
|
|
URG
3545
Ur-Energy
URG
$485M
| $625K | ﹤0.01% |
524,866
-1,095,965
| -68% | -$1.31M |
|
3546
PUT
Sarepta Therapeutics
SRPT
$1.57B
| $624K | ﹤0.01% |
+5,000
| New | +$691K |
|
3547
Neurogene
NGNE
$656M
| $623K | ﹤0.01% |
14,859
+11,316
| +319% | +$439K |
|
|
ONTF
3548
DELISTED
ON24
ONTF
| $623K | ﹤0.01% |
101,837
+33,352
| +49% | +$206K |
|
3549
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
| $623K | ﹤0.01% |
12,756
-44,930
| -78% | -$2.07M |
|
3550
Bankwell Financial Group
BWFG
$543M
| $622K | ﹤0.01% |
20,781
+6,710
| +48% | +$183K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.